受注:045-509-1970 |
技術サポート:[email protected] 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:A2041 Batch: A204101
Emapalumab (anti-IFNγ), a monoclonal antibody directed against IFNγ, is the first global approval for the treatment of pediatric and adult patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory.
CAS No. | 1709815-23-5 |
---|---|
Formulation | PBS Buffer, PH 7.4 |
Isotype | Human IgG1 |
Application | Emapalumab (anti-IFNγ) |
Storage (From the date of receipt) |
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles. |
Shipping | Shipped under low temperature conditions |
Purity | 99% |
Protein concentration | 4.04mg/ml |
Endotoxin Level | <1 EU/mg |
人間や獣医の診断であるか治療的な使用のためにでない。